The use of combinations of disease‐modifying antirheumatic agents in rheumatoid arthritis

Arthritis & Rheumatism

Volumn 33, Issue 1, 1990, Pages 113-120

  Paulus, Harold E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG COMBINATION; DRUG COMPARISON; DRUG THERAPY; GOLD THERAPY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMALARIALS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DRUG COMBINATIONS; GOLD; HUMAN; METHOTREXATE; PENICILLAMINE; SULFASALAZINE;

EID: 0025139699     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780330116     Document Type: Article

References (30)

1. Drug‐related disease remission in rheumatoid arthritis (abstract).
2. Treatment complications of rheumatoid arthritis treated with gold, hydroxychloroquine, D‐penicillamine, and levamisole.
3. Long‐term outcome of treating rheumatoid arthritis: results after 20 years.
4. Gold salt therapy does not alter the course of rheumatoid arthritis in adults (abstract).
5. Severe functional declines, work disability, and increased mortality in seventy‐five rheumatoid arthritis patients studied over nine years.
6. New therapies for rheumatic diseases.
7. Refractory RA patients: give cytotoxics next?
8. Use of antimalarials in the treatment of rheumatoid arthritis.
9. Current practice in antimalarial prescribing in rheumatoid arthritis.
10. Remodeling the pyramid: a concept whose time has come.
11. Antimalarial agents compared with or in combination with other disease‐modifying antirheumatic drugs.
12. Combined disease‐modifying chemotherapy for intractable rheumatoid arthritis.
13. Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA.
14. Prolonged remission of severe refractory rheumatoid arthritis following allogenic bone marrow transplantation for drug‐induced aplastic anaemia.
15. Intractable rheumatoid arthritis: treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.
16. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine: a follow‐up study.
17. Low‐dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: two years later (abstract).
18. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.
19. The combination of methotrexate and azathioprine for resistant rheumatoid arthritis (abstract).
20. Combination chemotherapy for severe rheumatoid arthritis.
21. The combined use of methotrexate and intramuscular gold in rheumatoid arthritis (abstract).
22. Combined therapy of rheumatoid arthritis with gold and chloroquine.
23. Combination therapy with gold and hydroxy‐chloroquine in rheumatoid arthritis: a prospective, randomized, placebo‐controlled study.
24. Controlled trial of hydroxychloroquine and D‐penicillamine singly and in combination in the treatment of rheumatoid arthritis.
25. Combined D‐penicillamine and chloroquine treatment of rheumatoid arthritis: a comparative study.
26. Sulphasalazine alone or in combination with D‐penicillamine in rheumatoid arthritis.
27. Sulphasalazine in rheumatoid arthritis: combination therapy with D‐penicillamine or sodium aurothiomalate.